138 related articles for article (PubMed ID: 14718095)
1. Flow cytometry and T-cell response monitoring after smallpox vaccination.
Poccia F; Gioia C; Montesano C; Martini F; Horejsh D; Castilletti C; Pucillo Lp; Capobianchi MR; Ippolito G
Emerg Infect Dis; 2003 Nov; 9(11):1468-70. PubMed ID: 14718095
[TBL] [Abstract][Full Text] [Related]
2. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
3. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
[TBL] [Abstract][Full Text] [Related]
4. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
Bricaire F; Combadière B; Rouleau E; Bossi P; Garin D; Lebrun-Vignes B; Autran B
Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
[TBL] [Abstract][Full Text] [Related]
6. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
Ennis FA; Cruz J; Demkowicz WE; Rothman AL; McClain DJ
J Infect Dis; 2002 Jun; 185(11):1657-9. PubMed ID: 12023773
[TBL] [Abstract][Full Text] [Related]
7. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
Bartlett JG
Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
[TBL] [Abstract][Full Text] [Related]
8. Duration of immunity after smallpox vaccination: a study on vaccination policy against smallpox bioterrorism in Japan.
Arita I
Jpn J Infect Dis; 2002 Aug; 55(4):112-6. PubMed ID: 12403907
[TBL] [Abstract][Full Text] [Related]
9. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
10. Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization.
Niemiałtowski MG; Toka FN; Malicka E; Gieryńska ; Spohr de Faundez I; Schollenberger A
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):373-8. PubMed ID: 9017154
[TBL] [Abstract][Full Text] [Related]
11. Dose-related effects of smallpox vaccine.
Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
[TBL] [Abstract][Full Text] [Related]
12. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
Wiser I; Balicer RD; Cohen D
Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
[TBL] [Abstract][Full Text] [Related]
13. Addressing challenges for allergists in vaccination to protect against smallpox.
Hackett CJ; Rotrosen D; Plaut M
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):1-3. PubMed ID: 15702805
[No Abstract] [Full Text] [Related]
14. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
[TBL] [Abstract][Full Text] [Related]
15. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
Meseda CA; Weir JP
Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
[TBL] [Abstract][Full Text] [Related]
16. Responses to smallpox vaccine.
Frelinger JA; Garba ML
N Engl J Med; 2002 Aug; 347(9):689-90; author reply 689-90. PubMed ID: 12201305
[No Abstract] [Full Text] [Related]
17. Age distribution for T cell reactivity to vaccinia virus in a healthy population.
Hsieh SM; Pan SC; Chen SY; Huang PF; Chang SC
Clin Infect Dis; 2004 Jan; 38(1):86-9. PubMed ID: 14679452
[TBL] [Abstract][Full Text] [Related]
18. The case for voluntary smallpox vaccination.
Bicknell WJ
N Engl J Med; 2002 Apr; 346(17):1323-5. PubMed ID: 11923492
[No Abstract] [Full Text] [Related]
19. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
[TBL] [Abstract][Full Text] [Related]
20. Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.
Kim SH; Choi SJ; Park WB; Kim HB; Kim NJ; Oh MD; Choe KW
Vaccine; 2007 Aug; 25(33):6287-91. PubMed ID: 17597266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
